5 Einträge gefunden

1. Survival Outcomes of Patients With Tropomyosin Receptor Kinase Fusion-Positive Cancer Receiving Larotrectinib Versus Standard of Care: A Matching-Adjusted Indirect Comparison Using Real-World Data

   1. Bokemeyer, Carsten
   2. Paracha, Noman
   3. Lassen, Ulrik
   4. Italiano, Antoine
   5. Sullivan, Sean D
   6. Marian, Marisca
   7. Brega, Nicoletta

   2023 - Forschungsinformationssystem des UKE - frei zugänglich
2. Prognostic Value of Neurotrophic Tyrosine Receptor Kinase Gene Fusions in Solid Tumors for Overall Survival:A Systematic Review and Meta-Analysis

   1. Lassen, Ulrik
   2. Bokemeyer, Carsten
   3. Garcia-Foncillas, Jesus
   4. Italiano, Antoine
   5. Vassal, Gilles
   6. Paracha, Noman
   7. Marian, Marisca

   2023 - Forschungsinformationssystem des UKE - frei zugänglich
3. Indirect Treatment Comparison of Larotrectinib versus Entrectinib in Treating Patients with TRK Gene Fusion Cancers

   1. Garcia-Foncillas, Jesus
   2. Bokemeyer, Carsten
   3. Italiano, Antoine
   4. Keating, Karen
   5. Paracha, Noman
   6. Fellous, Marc
   7. Marian, Marisca

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
4. Estimating Long-Term Survival Outcomes for Tumor-Agnostic Therapies: Larotrectinib Case Study

   1. Briggs, Andrew
   2. Paracha, Noman
   3. Rosettie, Katherine
   4. Upton, Alexander
   5. Bokemeyer, Carsten
   6. Lassen, Ulrik
   7. Sullivan, Sean D

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
5. Dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract cancer (ROAR):a phase 2, open-label, single-arm, multicentre basket trial

   1. Subbiah, Vivek
   2. Lassen, Ulrik
   3. Élez, Elena
   4. Italiano, Antoine
   5. Curigliano, Giuseppe
   6. Javle, Milind
   7. de Braud, Filippo

   2020 - Forschungsinformationssystem des UKE